Fractyl Health, Inc. Common Stock
NASDAQ:GUTSBiotechnology
Healthcare
$4.16 -0.81%
-$0.01 today
- Market cap
- $55.18M
- Beta
- 2.34
- P/E (TTM)
- -0.6
- EPS (TTM)
- -$1.42
52W Low $0.38High $2.45
Volume 0.10M
Average 2.07M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$96.82M
FY 2025 · Annual
Net Income
-$140.95M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 120K | 93K | 0 |
| Cost of Revenue | 0 | 452K | 77K | 50K | 0 |
| Gross Profit | 0 | (452K) | 43K | 43K | 0 |
| Gross Margin | — | — | 35.8% | 46.2% | — |
| Research & Development | 26.44M | 34.35M | 38.04M | 70.47M | 74.54M |
| Selling, General & Admin | 10.49M | 14.58M | 0 | 0 | 22.28M |
| Operating Expenses | 36.93M | 48.93M | 50.88M | 93.57M | 96.82M |
| Depreciation & Amortization | 676K | 452K | 286K | 677K | 1.13M |
| EBITDA | (36.62M) | (46M) | (76.81M) | (68.02M) | (139.83M) |
| EBITDA Margin | — | — | -64004.2% | -73136.6% | — |
| Operating Income | (36.93M) | (49.39M) | (50.84M) | (93.53M) | (96.82M) |
| Operating Margin | — | — | -42363.3% | -100571.0% | — |
| Interest Income | 0 | 797K | 1.26M | 4.15M | 1.54M |
| Interest Expense | 1.44M | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (1.81M) | 2.93M | (26.26M) | 24.84M | (44.14M) |
| Income Before Tax | (38.74M) | (46.45M) | (77.09M) | (68.69M) | (140.95M) |
| Pre-Tax Margin | — | — | -64242.5% | -73864.5% | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (38.74M) | (46.45M) | (77.09M) | (68.69M) | (140.95M) |
| Net Margin | — | — | -64242.5% | -73864.5% | — |
| EPS (Basic) | (1.12) | (1.34) | (1.98) | (1.62) | (1.86) |
| EPS (Diluted) | (1.12) | (1.34) | (1.98) | (1.62) | (1.86) |
| 47.61M | 47.61M | 47.61M | 43.54M | 75.82M | |
| 47.61M | 47.61M | 47.61M | 43.54M | 75.82M |
GUTS Earnings Waterfall · TTM
NASDAQ:GUTS · Revenue to Net Income
Key Ratios
EPS$-1.74
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-0.3
P/S Ratio0.0
Analysis
$0 of revenue converted into -$108.0M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.74, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Sep 24, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 16, 2026 | |
| 8-K | Current report | Sep 11, 2026 | |
| DEF 14A | DEF 14A filing | Aug 24, 2026 | |
| PRE 14A | PRE 14A filing | Aug 14, 2026 |
How much revenue does GUTS generate?
Fractyl Health, Inc. Common Stock (GUTS) reported $0.00 of revenue in fiscal 2025.
Is GUTS profitable?
Fractyl Health, Inc. Common Stock (GUTS) reported -$140.95M of net income.
Continue the stock analysis
Jump to another research area for this company.